Direct Acting Antiretrovirals

Awareness Is Key What You Need to Know About the Side Effect Profiles of New HCV Antiretrovirals by Larry Buhl By all accounts, adding the new direct-acting...

HCV & Underreporting

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C...

Man to Man

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the...

Process of Elimination

As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s...

The Silent C

A new recommendation report provides a global look at hepatitis C Hep Talk by Larry Buhl There’s good news and bad news about the hepatitis C...

Race to the Hep C Cure

Race to the Cure Who are the biggest players now in eradicating hepatitis C? by Larry Buhl Beyond the implementation of the Affordable Care Act, one of...

Equal HCV Treatment Benefits

A press conference at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) offered two main takeaways: that the new generation of oral direct-acting antiviral agents (DAAs) are highly effective and safe, and...

Medicaid HCV Blockade

Denial Many states restrict DAA coverage to the sickest of hep C patients by Larry Buhl When direct-acting antiretrovirals (DAAs) for hepatitis C were new, some private...

Care Costs

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

Cutting Glass

A study links anal sex & meth to increased HCV rates among MSMs by Larry Buhl LifeGuide For decades it has been the conventional wisdom that...

LATEST POSTS

Well With My Soul – An Excerpt

It seemed as if everyone had been trying to keep this secret from me for as long as they could. But Samantha was tired...

Dark Angel: An Excerpt

Remember When